BRCA2 Heterozygosity Delays Cytokinesis in Primary Human Fibroblasts
Background: Inherited mutations in the tumour suppressor gene BRCA2 greatly increase the risk of developing breast, ovarian and other types of cancers. So far, most studies have focused on the role of BRCA-pathways in the maintenance of genomic stability.
Saved in:
Main Authors: | Asta Björk Jonsdottir, Maaike P. G. Vreeswijk, Ron Wolterbeek, Peter Devilee, Hans J. Tanke, Jorunn E. Eyfjörd, Karoly Szuhai |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2009-01-01
|
Series: | Cellular Oncology |
Online Access: | http://dx.doi.org/10.3233/CLO-2009-0465 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Making the Final Cut — Mechanisms Mediating the Abscission Step of Cytokinesis
by: John A. Schiel, et al.
Published: (2010-01-01) -
Frequency and Significance of Abnormal Pancreatic Imaging in Patients with BRCA1 and BRCA2 Genetic Mutations
by: Elie Chahla, et al.
Published: (2016-01-01) -
The known genetic variants of BRCA1, BRCA2 and NOD2 in pancreatitis and pancreatic cancer risk assessment
by: Jarosław Matykiewicz, et al.
Published: (2025-01-01) -
The Carcinoma–Stromal Ratio of Colon Carcinoma Is an Independent Factor for Survival Compared to Lymph Node Status and Tumor Stage
by: Wilma E. Mesker, et al.
Published: (2007-01-01) -
Ductal Carcinoma In Situ (DCIS) Diagnosed by MRI-Guided Biopsy among BRCA1/BRCA2 Mutation Carriers
by: Renata Faermann, et al.
Published: (2022-01-01)